Aaron David Greenblatt, MD, University of Maryland School of Medicine Associate Professor of Family & Community Medicine and Psychiatry, has been awarded a Fulbright-Collegium fellowship. This prestigious award will support six months of research and teaching at Claude Bernard Lyon 1 University, in Lyon, France.

Beginning in September, Dr. Greenblatt and his French colleagues will conduct a comparative study of addiction care in French and U.S. correctional facilities and establish working trans-Atlantic partnerships between addiction training programs. He is interested in what lessons can be learned from the French approach, which offers universal access to opioid use disorder medications to all prisoners. In the U.S., by contrast, only 13% of jails offer all prisoners opioid use disorder medication.

Dr. Greenblatt currently serves as the Medical Director of the University of Maryland Medical Center Addiction Treatment Programs at 1001 West Pratt Street in Baltimore, which provides integrated primary care, psychiatry, and infectious disease care co-located with traditional addiction treatment. He also serves as the program director for the University of Maryland Addiction Medicine fellowship.

Offered through a partnership between the Franco-American Fulbright Commission and the Collegium de Lyon, or the Institute for Advanced Study of the University of Lyon, Fulbright-Collegium fellowships are awarded to scholars wishing to pursue innovative research and forge connections with academic colleagues. Fellows are provided grant funding and resources at one of three University of Lyon campuses, which collectively represent France’s second-largest research cluster.